Literature DB >> 1933780

Malignant epithelial tumors in the minor salivary glands, the submandibular gland, and the sublingual gland. Prognostic factors and treatment results.

L J Andersen1, M H Therkildsen, H H Ockelmann, J D Bentzen, T Schiødt, H S Hansen.   

Abstract

Ninety-five malignant tumors in the submandibular gland, the sublingual gland, and the minor salivary glands seen in a 25-year period were reviewed. The patients were retrospectively staged using the Union Internationale Contre le Cancer (UICC) classification. The most frequent tumor was adenoid cystic carcinoma, followed by adenocarcinoma. The submandibular gland was the most frequent location. Five-year and 10-year crude survival rates were 62% and 43%, respectively. Clinical stage was the most important prognostic factor. Survival was not correlated with location of tumor, although recurrence and metastases occurred more frequently in patients with cancer of the submandibular gland. Histologically, the 5-year and 10-year survival was significantly better for patients with adenoid cystic carcinoma compared with the other types; however, although still significant, this difference diminished at 10 years, confirming the need for a long observation time for patients with this tumor.

Entities:  

Mesh:

Year:  1991        PMID: 1933780     DOI: 10.1002/1097-0142(19911201)68:11<2431::aid-cncr2820681118>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

Review 1.  NUT Midline Carcinoma of the Sublingual Gland: Clinical Presentation and Review.

Authors:  Nolan B Seim; Ramez H W Philips; Lynn Schoenfield; Theodoros N Teknos; James W Rocco; Amit Agrawal; Enver Ozer; Ricardo L Carrau; Stephen Y Kang; Matthew O Old
Journal:  Head Neck Pathol       Date:  2017-03-27

2.  Tumors of the sublingual gland: a national clinicopathologic study of 29 cases.

Authors:  Simon Andreasen; K Bjørndal; T K Agander; I Wessel; P Homøe
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-25       Impact factor: 2.503

3.  Adenoid cystic carcinoma on the dorsum of the tongue.

Authors:  Subhalakshmi Sengupta; Anadi Roychowdhury; Palash Bhattacharya; Anjali Bandyopadhyay
Journal:  J Oral Maxillofac Pathol       Date:  2013-01

Review 4.  Diagnosis and management of malignant sublingual gland tumors: a narrative review.

Authors:  Minhae Park; Junhun Cho; Junsun Ryu; Han-Sin Jeong
Journal:  Gland Surg       Date:  2021-12

5.  Adenoid cystic carcinoma: A rare late presentation of the mobile tongue.

Authors:  Sanjay Kumar; Padmanidhi Agarwal; V Nimmi
Journal:  J Oral Biol Craniofac Res       Date:  2016-04-07

6.  Simultaneous pleomorphic adenoma of the left parotid gland and adenoid cystic carcinoma of the contralateral sublingual salivary gland: a case report.

Authors:  Nick Papadogeorgakis; Evagelos F Kalfarentzos; Christine Vourlakou; Fotini Malta; Dimitris Exarhos
Journal:  Oral Maxillofac Surg       Date:  2009-12

7.  Risk of nodal metastases from malignant salivary gland tumors related to tumor size and grade of malignancy.

Authors:  S Rodríguez-Cuevas; S Labastida; L Baena; F Gallegos
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

8.  Carcinoma ex pleomorphic adenoma of the sublingual gland: a case report.

Authors:  Yasunori Ariyoshi; Masashi Shimahara; Toshiyuki Konda; Motomu Tsuji
Journal:  Int J Oral Sci       Date:  2012-01-12       Impact factor: 6.344

Review 9.  Salivary gland neoplasms.

Authors:  Terry A Day; John Deveikis; M Boyd Gillespie; John K Joe; Besim Ogretmen; J David Osguthorpe; Susan G Reed; Mary S Richardson; Michael Rossi; Ranjiv Saini; Anand K Sharma; Robert K Stuart
Journal:  Curr Treat Options Oncol       Date:  2004-02

10.  Adenoid cystic carcinoma of the tongue--clinicopathological study and survival analysis.

Authors:  Kuauhyama Luna-Ortiz; Tania Carmona-Luna; Ana María Cano-Valdez; Adalberto Mosqueda-Taylor; Angel Herrera-Gómez; Verónica Villavicencio-Valencia
Journal:  Head Neck Oncol       Date:  2009-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.